Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01696734 · ClinicalTrials.gov registry record · Phase 3
Domperidone in Treating Patients With Gastrointestinal Disorders
A Phase 3 study of Gastroparesis and Gastroesophageal Reflux Disease, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT01696734 is a Phase 3 study of Gastroparesis and Gastroesophageal Reflux Disease that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 200 participants, below the 298-participant average among 44 other Gastroparesis trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01696734, a Phase 3 study of Gastroparesis and Gastroesophageal Reflux Disease, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase III trial studies how well domperidone works in treating patients with gastrointestinal disorders. Domperidone may help control chronic gastrointestinal disorders and their symptoms, such as pain, bloating, and nausea and vomiting, by stimulating contraction of the stomach to increase its ability to empty itself of food.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- DRUG Domperidone
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-10-23 |
| Est. Completion | 2027-10-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01696734
The ClinicalTrials.gov registry entry for NCT01696734 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 298-participant average among 44 other Gastroparesis trials with a reported enrollment target (33% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Gastroparesis appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT01696734 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01696734 about?
NCT01696734 is a clinical study titled "Domperidone in Treating Patients With Gastrointestinal Disorders". This phase III trial studies how well domperidone works in treating patients with gastrointestinal disorders. Domperidone may help control chronic gastrointestinal disorders and their symptoms, such as pain, bloating, and nausea and vomiting, by stimulating contraction of the stomach to increase its...
What is the current status of trial NCT01696734?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2012-10-23. Estimated completion is 2027-10-31.
What conditions does trial NCT01696734 study?
This clinical trial studies the following conditions: Gastroparesis, Gastroesophageal Reflux Disease, Dyspepsia, Heartburn, Nausea and Vomiting.
What interventions are being tested in trial NCT01696734?
The interventions under investigation include: Questionnaire Administration (OTHER), Domperidone (DRUG).
Who is sponsoring clinical trial NCT01696734?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01696734 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sancuso® for Gastroparesis: An Open Label Study.
COMPLETED · Phase 3
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.